Kosaraju Sridhar
- SEC CIK
- 0001651325
No open-market purchases or sales filed in the past year.
Current role at each company
- TXG 10x Genomics, Inc.Directoras of Jun 8, 2026
- NVRO Nevro CorpDirectoras of Apr 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kosaraju Sridhar as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TXG 10x Genomics, Inc.
Director6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 (view filing) | Dec 30, 2021 | 5 days | Kosaraju SridharDirector | SSaleClass A Common Stock | −1.50K | $150.38 | −$225.6K | −33.3%3.00K after | |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Kosaraju SridharDirector | SSaleClass A Common Stock | −1.50K | $150.06 | −$225.1K | −25.0%4.50K after | |
| Oct 27, 2021 (view filing) | Oct 25 | 2 days | Kosaraju SridharDirector | SSaleClass A Common Stock | −1.50K | $166.32 | −$249.5K | −20.0%6.00K after | 5 lots |
| Sep 24, 2021 (view filing) | Sep 23 | 1 day | Kosaraju SridharDirector | SSaleClass A Common Stock | −1.50K | $159.04 | −$238.6K | −16.7%7.50K after | 2 lots |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Kosaraju SridharDirector | SSaleClass A Common Stock | −1.50K | $162.06 | −$243.1K | −14.3%9.00K after | 5 lots |
| Jul 26, 2021 (view filing) | Jul 23 | 3 days | Kosaraju SridharDirector | SSaleClass A Common Stock | −1.50K | $183.67 | −$275.5K | −12.5%10.5K after | 4 lots |